Edgardo S. Santos/theoncologyinstitute.com
Sep 21, 2024, 14:06
Edgardo S. Santos: PCR after neoadjuvant is still not enough for cure
Edgardo S. Santos, Vice President of Florida Society of Clinical Oncology and Medical Director of Broward County of Florida at The Oncology Institute of Hope and Innovation, shared a post on X:
”What have I learned after a great session of Immuno-Oncology (IO) in ESMO24? A great presentation by Dr. Reuss on biomarkers analysis from neoadjuvant Immuno-Oncology: the role of STK11, KEAP1, and SMARCA4 could be very important for patient selection in the future. Also, PCR after neoadjuvant is still not enough for cure.”
Source: Edgardo S. Santos/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 7, 2025, 07:11
Sep 7, 2025, 06:55
Sep 7, 2025, 06:48
Sep 7, 2025, 06:44
Sep 7, 2025, 06:33
Sep 7, 2025, 06:07
Sep 7, 2025, 06:06
Sep 7, 2025, 05:55
Sep 7, 2025, 05:46
Sep 7, 2025, 05:24